Recent advances in biologic medicines have revolutionized the treatment of many illnesses and conditions, from cancer to autoimmune diseases and many others. The FDA is also approving an increasing number of biologic treatments – including biosimilars – which means patients and physicians have more treatment options than ever before.

Today, the Patient Access & Affordability Project released the Patients’ Guide to Biologic Treatment Options, a short document intended to help patients better understand these options, whether they are originator biologics or any available biosimlar options.


Read the Patients’ Guide